Egis receives the Top Employer 2026 recognition
Thu, Jan 15, 2026 3:32 PM
Egis Pharmaceuticals Plc. once again received the Top Employer Hungary certification in 2026, which is the result of an assessment based on an independent, international methodology. More

Dennis Gábor Award: Two laureates’ achievements are linked to Egis

For his outstanding innovation activities, Dr. Balázs Volk, Director of Drug Substance Development at Egis, received the Dennis Gábor Award, while Dr. Pál Fekete, retired Head of Pharmaceutical Technology Operations, was honored with the Dennis Gábor Lifetime Achievement Award. The award serves as a heightened moral recognition for Hungarian professionals who play a creative role in the innovation process and pursue exceptional scientific and R&D activities. Considering all fields of science, only about seven nominated individuals receive this honor each year. The fact that among the awardees we can celebrate both an active and a retired colleague demonstrates the high quality of scientific work and advanced innovation capabilities at Egis.
Dec. 16.
More

Egis Pharmaceuticals PLC inaugurates new active ingredient manufacturing plant

Egis Pharmaceuticals PLC has inaugarated one of the largest active pharmaceutical ingredient (API) investments in its 112-year history in Budapest. The new HUF 30 billion plant, financed from the company’s own resources, will produce the active ingredient of a globally market-leading medicine, featuring numerous technological innovations.
Nov. 20.
More

Egis Commits to Voluntary Price Cap

As a key player in the Hungarian pharmaceutical industry, Egis is voluntarily joining the initiative of the Ministry of National Economy aimed at curbing the price increases of Reparon Ointment 30g.
Jun. 12.
More
Mar. 08.

Egis Supported the Conference of the Hungarian Association of Private Pharmacists

The main theme of the online event was the operation of pharmacies during the pandemic.

More
Mar. 08.

A Decade-Long Commitment to the Treatment of Cancer

We have commemorated World Cancer Day.

More
Feb. 22.

Egis Next Generation Celebrates One Year Anniversary

More than just a traineeship program: besides professional experience, career coaching, trainings and community experience await the participants.

More
Feb. 19.

“Egis - Pharma A-Z” Course Launched at the University of Szeged

Egis’ popular credit-point course is now offered in four Hungarian universities.

More
Feb. 15.

Shaping the future – Egis joins the Edison platform initiative

How to prepare the next generations for an ever-changing world?

More
Feb. 12.

Discover the Hungarian Medicine brand

It has been almost 110 years since dr. Sándor Balla, the Hungarian pharmacist fulfilled his dream and the predeccessor of Egis was established in Budapest. Ever since then, our objective has remained unchanged: to provide Hungarian medicines of the highest quality to people, so that they can lead a long and healthy life.

More
Jan. 28.

Egis Celebrates 20th Anniversary in Vietnam

Egis today is among the Top50 foreign companies operating in Vietnam.

More
Jan. 22.

Pharmaceutical industry is one of the key players of the Hungarian economy

The performance of the Hungarian pharmaceutical industry in the last ‘peaceful year’ before the coronavirus epidemic was reviewed in a comprehensive analysis by Nézőpont Institute on behalf of 16 pharmaceutical companies of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ).

More
Jan. 14.

Happy eco-friendly Holidays!

Trees from paper: Aiming to reduce the number of corporate paper greeting cards, our initiative has been a great success this year as well: in December 95% less cards were sent out than two years ago. Egis will spend the saved amount on planting – the project therefore doubly serves the purpose of protecting our nature.

More
Jan. 06.

How to handle isolation during pandemic?

People-centric approach and swift adaptation are Egis’ responses.

More
Dec. 22.

Hand sanitizer stations – for the safety of pharmacists and patients

Disinfection plays an important role in reducing the risk of infection. As a responsible company, Egis supports the safe operation of pharmacies in the second wave of the coronavirus pandemic as well.

More
Dec. 15.

Digital knowledge sharing for professionals

As restrictions came into force due to the pandemic situation in spring, several processes at Egis have been moved to the digital space.

More

Submit
Submit

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox